文献速递消化道肿瘤与早癌

手术不足导致食管癌生存时间的种族差异:一项匹配队列研究

Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-07-20

本研究基于SEER-Medicare数据库,纳入1994至2011年确诊的1900例黑人和15523例非西班牙裔白人食管癌患者(≥65岁),依次按人口学、临床表现和治疗因素进行匹配。匹配治疗因素后5年生存率的种族差异消失(P=.59),而按临床表现匹配时仅10.8%黑人患者接受手术,非西班牙裔白人为22.8%(P<.001)。结论认为手术不足可解释黑人与非西班牙裔白人食管癌患者的生存差异。

要点

  • 按人口学匹配时黑人5年生存率13.3%,非西班牙裔白人18.4%,绝对差5.1%(95%CI 2.3%-7.7%,P=.001)。
  • 按临床表现匹配后5年生存率差缩小至2.3%(95%CI 0.3%-4.8%),仍有统计学显著性(P=.04)。
  • 进一步匹配治疗因素后种族生存差异消失(P=.59);临床表现匹配组黑人手术率10.8% vs 非西班牙裔白人22.8%(P<.001)。

核心结论

  • 在SEER-Medicare数据库中,手术不足可解释黑人与非西班牙裔白人食管癌患者之间的生存时间差异。

研究设计与样本

  • 匹配队列研究,纳入SEER-Medicare数据库1994至2011年确诊的1900例黑人和15523例非西班牙裔白人食管癌患者,年龄≥65岁,随访至死亡或2012年12月31日。
  • 将三组各1900例非西班牙裔白人患者依次与同一组1900例黑人患者匹配,分别基于人口学、临床表现和治疗因素。

主要发现

  • 人口学匹配时黑人5年生存率13.3%,非西班牙裔白人18.4%,绝对差5.1%(95%CI 2.3%-7.7%,P=.001)。
  • 临床表现匹配后5年生存率差缩小至2.3%(95%CI 0.3%-4.8%),仍有统计学显著性(P=.04)。
  • 进一步匹配治疗因素后5年生存率的种族差异消失(P=.59)。
  • 临床表现匹配组中黑人手术率10.8%,非西班牙裔白人22.8%(P<.001)。
  • 组织学、肿瘤位置、社会经济状态、化疗和放疗均与是否接受手术相关,但均不能解释手术接受率的种族差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There are racial disparities in survival times of patients with esophageal cancer. We examined the sequential effects of characteristics, diagnosis, and treatment-related factors on the disparity in survival times of black vs white patients with esophageal cancer. METHODS: We identified 1900 black and 15,523 non-Hispanic white (NHW) patients, 65 years or older, diagnosed with esophageal squamous cell carcinoma or esophageal adenocarcinoma from 1994 through 2011 in the Surveillance Epidemiology and End Results (SEER)-Medicare database. Patients were followed up until death or December 31, 2012. Three sets of 1900 NHW patients were matched sequentially to the same set of 1900 black patients, based on demographics (age, sex, year of diagnosis, and SEER site), presentation (demographics plus cancer stage, grade, and comorbidity), and treatment (presentation variables plus surgery, chemotherapy, or radiation therapy). RESULTS: The absolute difference in 5-year survival between black patients (13.3%) and NHW patients (18.4%) was 5.1% (95% CI, 2.3%-7.7%; P = .001) in the demographics match. After we matched for presentation, the difference in 5-year survival was reduced to 2.3% (95% CI, 0.3%-4.8%), but remained statistically significant (P = .04). Additional matching of patients on treatment-related factors eliminated the racial difference in 5-year survival (P = .59). Among patients matched for disease presentation, only 10.8% of black patients underwent surgery, compared with 22.8% of NHW patients (P < .001). Histology, tumor location, socioeconomic status, chemotherapy, and radiation therapy each were associated with the receipt of surgery. None of these factors, however, could explain the racial difference in the receipt of surgery. CONCLUSIONS: In the SEER-Medicare database, underuse of surgical treatment can account for the disparities in survival times between black and NHW patients with esophageal cancer.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Dong J, Gu X, El-Serag HB, et al. Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. Clin Gastroenterol Hepatol. 2018. PMID: 30036643. doi:10.1016/j.cgh.2018.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。